November 20, 2014 / 7:08 AM / 3 years ago

BRIEF-DBV Technologies starts Viaskin milk trial for children with cow milk allergy

Nov 20 (Reuters) - DBV Technologies SA :

* Initiates phase I/II clinical trial with Viaskin milk for treatment of children with cow's milk allergy

* Enrolling cow's milk-allergic subjects in phase I/II clinical study to evaluate safety and efficacy of Viaskin milk

* Viaskin milk is epicutanous patch for treatment of children with IgE-mediated cow's milk allergy (CMA) Source text for Eikon: Further company coverage: (gdynia.newsroom@thomsonreuters.com; +48 58 698 3920)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below